Replies to post #59082 on Biotech Values

[DewDiligence]

MNTA – A few of the insiders are affiliates of institutional owners; hence the double counting in your calculation.

[DFRAI]

very little stock being offered. not much in circulation. I think they trade a large portion of it hoping to entice sellers. it seems to me, that mnta is poised for a nice run in not too distant future.

[DewDiligence]

MNTA Insider Shareholdings
(*10b5-1 selling plan in effect)

 
 Executive Officers  
 Craig Wheeler, CEO         275K shares   395K options 
 Steven Brugger, COO        261K shares   128K options 
 Richard Shea, CFO           17K shares   174K options 
 G. Venkataraman, SVP R&D   453K shares   110K options 
 *John Bishop, SVP Pharma    29K shares   164K options 
 *Lisa Shmerling, VP Legal    0K shares    63K options 
 *S. Whoriskey, VP Bus Dev   69K shares    66K options 
  
 -- 
 Seven executive officers 1,104K shares 1,100K options

 
 Non-executive directors  
 Peter Barrett (Atlas)    2,459K shares    77K options 
 John Clarke (Cardinal Prt) 558K shares    77K options 
 Alan Crane (Polaris)       586K shares    54K options 
 Marsha Fanucci                0 shares    77K options 
 Peter Hutt                  67K shares   156K options 
 Robert Langer              970K shares    77K options 
 Stephen Reeders (MVM)    1,383K shares    77K options 
 *Ram Sasisekharan          406K shares    77K options 
 *Bennett Shapiro             7K shares   109K options 
 Elizabeth Stoner              0 shares    30K options 
 -- 
 10 non-executive dirctrs 6,436K shares   811K options

 
 All officers/directors   7,540K shares 1,911K options